We Compared the Covid-19 Acute Respiratory Distress Syndrome (ARDS) Patients Who Applied Prone Positioning for16-24 Hours vs 24-48 Hours
''Impact of Early vs. Delayed Prone Positioning on Oxygenation and Mortality in COVID-19 ARDS Patients: A Retrospective Analysis''
1 other identifier
observational
350
1 country
1
Brief Summary
The goal of this study is to understand if there is any improvement on oxygenation of patients diagnosed with Covid-19 ARDS patients when we extend the duration of prone positioning. Second outcome of the study is to investigate mortality of patients when we extend the duration of prone positioning.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 3, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 15, 2024
CompletedFirst Submitted
Initial submission to the registry
July 30, 2024
CompletedFirst Posted
Study publicly available on registry
July 31, 2024
CompletedJuly 31, 2024
July 1, 2024
3 months
July 30, 2024
July 30, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Oxygen Saturation Index (OSI)
OSI is calculated by dividing the product of mean airway pressure (MAP) and FiO2 with SpO2
48 hours
Oxygenation Index
Oxygenation index is calculated as OI = MAP × Fio2 × 100 / Pao2, where MAP indicates mean airway pressure and Fio2 indicates fraction of inspired oxygen
48 hours
Secondary Outcomes (1)
ICU mortality
28 days
Study Arms (2)
Group A
Patients who have been in prone positioning for 16-24 hours
Group B
Patients who have been in prone positioning for 24-48 hours
Interventions
Eligibility Criteria
Patients who have been admitted in ICU and diagnosed with Covid-19 ARDS.
You may qualify if:
- COVİD 19 ARDS patients patients who have been intubated for 48 hours and more
You may not qualify if:
- Pediatric patients Patients who extubated in less than 48 hours Patients with Lung and pleural malignancies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bakirkoy Dr Sadi konuk Research and Training hospital
Istanbul, 34450, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 30, 2024
First Posted
July 31, 2024
Study Start
October 3, 2022
Primary Completion
January 3, 2023
Study Completion
February 15, 2024
Last Updated
July 31, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share